Experimental cocktail takes on toughest pancreatic cancer
Disease control
Not yet recruiting
This early-stage trial tests whether adding ATRA, SDK002, and an immunotherapy drug to standard chemotherapy is safe for people with advanced pancreatic cancer that cannot be removed by surgery. Ten participants will receive all five drugs together. The study will also track how …
Phase: PHASE1 • Sponsor: Daniel Breadner • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC